Suggestions
Daniel Schroen
Cell, Gene, Viral Vector, Bio-Based Advanced Therapies - Rare Diseases
Professional Background
Daniel Schroen, PhD, is a highly accomplished professional in the life sciences industry, bringing extensive expertise and insight honed through rigorous academic achievement and significant industry experience. A science-literate business strategist, Dr. Schroen's career trajectory is marked by his dedication to advancing the field of biotechnology through innovative multi-omics solutions, cell-, gene-, and tissue-based products, as well as transformative therapies. His journey encompasses roles at both large multinational corporations and agile startups, enabling him to amass a wealth of experience in consultative technical selling, strategic business development, product management, and complex multi-channel marketing across diverse sectors including pharmaceutical, contract research organizations (CROs)/contract development and manufacturing organizations (CDMOs), academic research, and drug discovery and development.
Dr. Schroen possesses specialized knowledge in areas such as cell lines, primary cells, beta islets, CAR-T cell therapy, induced pluripotent stem cells (iPSCs) and their derivatives, as well as the corresponding specialty media and supplements necessary for their cultivation and application. His understanding of advanced therapeutics extends to the realms of cell, gene, protein/antibody, and viral vector/vaccine-based therapies, positioning him as a formidable leader in the life sciences domain. He has excelled in overseeing product lifecycles and managing sales opportunity funnels, ensuring a seamless transition from development to market launch for the innovative products he champions.
Education and Achievements
Daniel Schroen’s educational foundation is exceptional, beginning with a Bachelor of Science in Biological Sciences (3.89/4.00) from Illinois State University, where he demonstrated his commitment to academic excellence. He further pursued a Doctor of Philosophy (Ph.D.) in Cell Biology & Immunology, maintaining an impressive GPA of 4.0/4.0, which showcases his deep understanding of complex biological systems. Dr. Schroen also completed a postdoctoral fellowship in Molecular and Cellular Biology at the Geisel School of Medicine at Dartmouth, solidifying his expertise in the molecular mechanisms that underpin health and disease.
Throughout his career, Dr. Schroen has held numerous prestigious positions that reflect his leadership and innovative capabilities. He served as Lead of Photo 51 at Fingerpaint, overseeing strategic initiatives that integrate scientific advancements with marketing efforts. His previous roles include Account Development for NAFLD/NASH at Reveal Biosciences, where he played a pivotal role in developing market strategies tailored to address pressing health challenges. Dr. Schroen's time at Nucleus Biologics included significant contributions as both a Lead Generation Consultant and Commercial Lead, R&D, where he developed and executed business strategies that propelled company growth.
As the Marketing Director at WuXi Advanced Therapies, Dr. Schroen was instrumental in shaping marketing strategies for advanced therapeutics. His tenure as Vice President and Director of Sales West at Nucleus Biologics and Vice President of Sales and Marketing at Cell Applications, Inc. further underscore his potential for driving revenue growth and strategic partnerships.
Achievements
Daniel Schroen’s achievements within the life sciences industry are numerous and noteworthy. He has successfully built scientific advisory groups that bring transformative ideas and innovative technologies back into organizations, illustrating his ability to synergize scientific advancements with commercial interests. His approach often embraces an omni-channel marketing strategy—encompassing upstream and downstream, inbound and outbound tactics, and both traditional and digital methodologies—ensuring that products reach the right audiences effectively and efficiently.
Moreover, his extensive background has equipped him with the skills necessary to navigate complex market environments, allowing him to thrive in various capacities from startup ecosystems to established corporations. Dr. Schroen's proficiency in advanced therapeutics has made him a sought-after expert in the fields of cell therapy and oncology, and he is frequently consulted for his insights and expertise in these critical areas.
Dr. Schroen has consistently demonstrated an unwavering commitment to leveraging scientific knowledge in business strategy, making significant impacts on every organization he has been a part of. By fostering collaborative environments and empowering teams, he has enhanced productivity and innovation, resulting in successful product launches and impactful therapeutic solutions. His strategic foresight and ability to integrate science with marketplace demands position him as a quintessential leader in the biotechnology sector.
tags':['life sciences','biotechnolog
